Boule Diagnostics AB Share Price Nasdaq Stockholm
Equities
SE0000437402
Advanced Medical Equipment & Technology
Sales 2024 * | 580M 53M 4.42B | Sales 2025 * | 620M 56.7M 4.73B | Capitalization | 381M 34.79M 2.9B |
---|---|---|---|---|---|
Net income 2024 * | 28M 2.56M 213M | Net income 2025 * | 41M 3.75M 312M | EV / Sales 2024 * | 0.79 x |
Net Debt 2024 * | 77.93M 7.12M 594M | Net Debt 2025 * | 75.63M 6.91M 576M | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
13.2
x | P/E ratio 2025 * |
9.09
x | Employees | - |
Yield 2024 * |
2.09% | Yield 2025 * |
3.47% | Free-Float | 61.67% |
Latest transcript on Boule Diagnostics AB
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | 01/01 |
Aishat Bislieva
HRO | Human Resources Officer | - | 01/22/01 |
Fredrik Ekdahl
PRN | Corporate Officer/Principal | - | 01/12/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 01/21/01 | |
Chairman | 72 | 01/21/01 | |
Director/Board Member | 57 | 01/14/01 |
1st Jan change | Capi. | |
---|---|---|
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |